- Previous Close
0.4340 - Open
0.4320 - Bid 0.4320 x --
- Ask 0.4560 x --
- Day's Range
0.4320 - 0.4320 - 52 Week Range
0.3250 - 0.8750 - Volume
10,000 - Avg. Volume
238 - Market Cap (intraday)
12.96M - Beta (5Y Monthly) 0.77
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4900 - Earnings Date Mar 4, 2025 - Mar 10, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness solutions in Australia and internationally. The company offers medicinal cannabis under the Wellness Life brand; topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; sleep aid products under the Nighty Night brand; caffeine energy supplements under the Wakey Wakey brand; iron gummies under The Iron Company brand; teeth whitening products under the Mr Bright brand; over-the-counter medicines under the Pharmacy Own brand; and pain relief product under the Wagner Liquigesics brand. It also provides organic baby skincare, aromatherapy essential oils, and domestic cleaning products; and contract manufacturing services. In addition, the company licenses intellectual properties and trademarks of its products. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
wellnexlife.com.auRecent News: 22W0.F
View MorePerformance Overview: 22W0.F
Trailing total returns as of 12/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 22W0.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 22W0.F
View MoreValuation Measures
Market Cap
13.30M
Enterprise Value
19.15M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.72
Price/Book (mrq)
3.57
Enterprise Value/Revenue
1.89
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-81.12%
Return on Assets (ttm)
-20.17%
Return on Equity (ttm)
-412.95%
Revenue (ttm)
16.94M
Net Income Avi to Common (ttm)
-13.74M
Diluted EPS (ttm)
-0.4900
Balance Sheet and Cash Flow
Total Cash (mrq)
956k
Total Debt/Equity (mrq)
176.02%
Levered Free Cash Flow (ttm)
3.76M